Recombinant Human BTNL9 (C-Fc)

Recombinant Human BTNL9 (C-Fc)

Size1:10μg price1:$136
Size2:50μg price2:$378
Size3:500μg price3:$1920 SKU: PHH2297 Category: Target Proteins Tags: ,

Datasheet

Name

Recombinant Human BTNL9 (C-Fc)

Purity

Greater than 95% as determined by reducing SDS-PAGE

Endotoxin level

<1 EU/µg as determined by LAL test.

Construction

Recombinant Human Butyrophilin-like Protein 9 is produced by our Mammalian expression system and the target gene encoding Ser35–Lys256 is expressed with a human IgG1 Fc tag at the C-terminus.

Accession #

Q6UXG8

Host

Human Cells

Species

Human

Predicted Molecular Mass

52 KDa

Buffer

Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.

Form

Lyophilized

Shipping

The product is shipped at ambient temperature.Upon receipt, store it immediately at the temperature listed below.

Stability&Storage

Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles.

Reconstitution

Always centrifuge tubes before opening.Do not mix by vortex or pipetting.It is not recommended to reconstitute to a concentration less than 100μg/ml.Dissolve the lyophilized protein in distilled water.Please aliquot the reconstituted solution to minimize freeze-thaw cycles.

 

 

 

Alternative Names

Butyrophilin-like protein 9; BTNL9

 

Background

Butyrophilin-Like Protein 9 (BTNL9) is single-pass type I membrane protein member of the BTN/MOG family that belongs to the immunoglobulin superfamily. BTNL9 consists of two domains: one B30.2/SPRY domain and one Ig-like V-type (immunoglobulin-like) domain. Human BTNL9 mRNA has been identified in adipose, lung, thymus, spleen, colon, and cardiac tissues, but its highest levels of expression were found in B cells. BTNL9 expression has also been found to be down-regulated in colon cancer tumors.

 

Note

For Research Use Only , Not for Diagnostic Use.

 

Related products